Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteins

Fig. 2

Distribution and median values of the oxidation rate of DHR (ORD) of ultracentrifuged HDL fractions (UCHDL) from apparently healthy subjects (Controls) and patients with the cardiovascular disease (CVD patients), and of apoB-deleted (apoBd) plasma from Controls, CVD patients, and patients with high serum amyloid A protein levels (High SAA patients). Differences between groups were tested by Mann-Whitney U test

Back to article page